phrykt

cbdMD, Inc. (YCBD): who owns it and who trades it

As of Nov 16, 2026, YCBD insiders reported 3 open-market sales worth $1.3M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Clark R. Crosnoe (10% owner), with $1.3M. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling cbdMD

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, YCBD insiders reported $0 of open-market purchases and $1.3M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$1.3M
3 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Dec 17, 2025
Filed Dec 19, 2025

Purchases and sales by month

$1.3M$1.3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Dec 17, 2025Clark R. Crosnoe10% ownerSale69,875$2.34$164KForm 4
Dec 17, 2025Clark R. Crosnoe10% ownerSale19,101$2.34$44.7KForm 4
Dec 17, 2025Clark R. Crosnoe10% ownerSale461,725$2.31$1.1MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Clark R. Crosnoe10% owner–$1.3MDec 17, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

YCBD short interest

Low short interest. 4.3% of YCBD shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went down 37%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 482,585 YCBD shares were sold short, 4.3% of the shares outstanding, down 11.6% from the report before. At the average daily volume of 65,254 shares, buying them all back would take about 7.4 trading days (days to cover).

Shares short, % of all shares

4.31%May 15Oct 307.80%

Days to cover

7.4May 15Oct 308.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026482,5854.31%-12%65,2547.4
Oct 15, 2026546,0324.87%-11%101,3645.4
Sep 30, 2026611,1025.45%+20%1.56M1.0
Sep 15, 2026511,1134.56%-2%269,4291.9
Aug 31, 2026522,4674.66%+6%91,5525.7
Aug 14, 2026493,2494.40%-7%242,9862.0
Jul 31, 2026527,6965.03%-6%203,2872.6
Jul 15, 2026560,9855.34%+2%264,6902.1
Jun 30, 2026550,0985.24%-7%166,0883.3
Jun 15, 2026593,6335.66%-11%150,4304.0
May 29, 2026668,7456.37%-13%211,0923.2
May 15, 2026770,9477.35%-17%466,1101.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

cbdMD company events

cbdMD filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026DealAs previously reported in the Current Report on Form 8-K filed by cbdMD, Inc. with the Securities and Exchange Commission, on September 2, 2026, the Company entered into an Asset Purchase Agreement dated September 1, 2026 by and among the Company, To Be Brands, LLC, a North Carolina limited… Filing
  2. Sep 2, 2026AgreementCbdMD, Inc. entered into an Asset Purchase Agreement by and among the Company, To Be Brands, LLC, a North Carolina limited liability company and wholly owned subsidiary of the Company, Twinlab Consolidated Holdings, Inc., a Nevada corporation, the wholly owned direct and indirect subsidiaries of… Filing
  3. May 20, 2026AgreementCbdMD, Inc. entered into a Third Amendment to Lease to extend the Warehouse Lease entered into on August 27, 2019, as amended, located at 2101 Westinghouse Boulevard, Suite A, Charlotte, North Carolina 28273. Filing
  4. Apr 15, 2026AnnouncementThe board of directors of cbdMD, Inc. issued each independent director and the non-management employee director 1,572 of the Company restricted stock units as compensation for services as a director for the term beginning on March 31, 2026. Filing
  5. Apr 1, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
  6. Jan 14, 2026AgreementCbdMD, Inc., a North Carolina corporation and Gaia Botanicals, LLC, a Colorado limited liability company and Gaia’s wholly owned subsidiaries entered into an Asset Purchase Agreement. Filing
  7. Dec 8, 2025AnnouncementThe Company received a letter from NYSE Regulation confirming that the Company has regained compliance with the Exchange. Filing
  8. Nov 28, 2025LeadershipCbdMD, Inc., a North Carolina corporation entered into an Executive Employment Agreement with T. Ronan Kennedy, the Company’s Chief Executive Officer and Chief Financial Officer. Filing
  9. Nov 25, 2025ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

cbdMD financials

Famous investors that hold YCBD

1 of the 50 well-known investors we track reported holding YCBD in their latest 13F filing. The largest position is Ken Griffin's, worth $42.1K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202692,971$42.1K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named YCBD in the last 120 days.

FiledHolderFormStake
Nov 4, 2026Akretive Holdings LLC13D15.9%
Nov 4, 2026Akretive Holdings LLC13D15.9%

Questions about cbdMD, Inc. (YCBD) stock

Are YCBD insiders buying or selling?

In the last 12 months, YCBD insiders reported no open-market purchases and 3 sales worth $1.3M. The latest trade was on Dec 17, 2025. See every trade.

What is the short interest in YCBD?

As of Oct 30, 2026, 482,585 YCBD shares were sold short, 4.3% of the shares outstanding, down 11.6% from the report before. At the average daily volume of 65,254 shares, buying them all back would take about 7.4 trading days (days to cover). See the history.

Which famous investors hold YCBD?

1 of the 50 well-known investors we track reported YCBD in their latest 13F filing, including Ken Griffin. The largest position is worth $42.1K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.